RFK
Riboflavin kinase
Also known as: FLJ11149, RIFK, RIFK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969G6
- Gene
- RFK
- Ensembl
- ENSG00000135002
- Chromosome
- 9
- Canonical length
- 155 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Riboflavin kinase (RFK; EC 2.7.1.26) is an essential enzyme that catalyzes the phosphorylation of riboflavin (vitamin B2) to form flavin mononucleotide (FMN), an obligatory step in vitamin B2 utilization and flavin cofactor synthesis (Karthikeyan et al., 2003 [PubMed 12623014]).[supplied by OMIM, Nov 2009]
Canonical amino-acid sequenceUniProt
155 residues, UniProt reviewed canonical sequence.
>Q969G6|RFK
1 MRHLPYFCRG QVVRGFGRGS KQLGIPTANF PEQVVDNLPA DISTGIYYGW ASVGSGDVHK
61 MVVSIGWNPY YKNTKKSMET HIMHTFKEDF YGEILNVAIV GYLRPEKNFD SLESLISAIQ
121 GDIEEAKKRL ELPEHLKIKE DNFFQVSKSK IMNGHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 32 nTPM
- duodenum: 31 nTPM
- hippocampal formation: 30 nTPM
- colon: 29 nTPM
- basal ganglia: 28 nTPM
- stomach: 27 nTPM
Single-cell type
- extravillous trophoblasts: 490 nCPM
- migrating cytotrophoblasts: 238 nCPM
- early spermatids: 203 nCPM
- parietal cells: 173 nCPM
- syncytiotrophoblasts: 165 nCPM
- late spermatids: 142 nCPM
Immune cell
- non-classical monocyte: 21 nTPM
- intermediate monocyte: 20 nTPM
- myeloid DC: 12 nTPM
- total PBMC: 9.8 nTPM
- classical monocyte: 9.7 nTPM
- NK-cell: 8.5 nTPM
Brain region
- hypothalamus: 49 nTPM
- pons: 49 nTPM
- hippocampal formation: 34 nTPM
- midbrain: 30 nTPM
- basal ganglia: 29 nTPM
- cerebral cortex: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- -0.31
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- flavin adenine dinucleotide biosynthetic process
- reactive oxygen species metabolic process
- riboflavin metabolic process
- FMN biosynthetic process
- positive regulation of NAD(P)H oxidase activity
- riboflavin biosynthetic process
Molecular functions
- ATP binding
- metal ion binding
- riboflavin kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Riboflavin kinase domain, bacterial/eukaryotic
- Riboflavin kinase domain superfamily
- Riboflavin kinase
- Riboflavin kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RFK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFK as an antibody target. Whether an autoantibody or antibody against RFK could matter depends on whether native RFK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...